Patients with grass pollen-induced allergic rhinoconjunctivitis show good levels of treatment satisfaction when treated with a five-grass pollen tablet sublingual immunotherapy in routine clinical practice.

Patients experienced good symptom control, had less need for symptomatic medication and reported that five-grass pollen tablet was well tolerated.